Bellicum Pharmaceuticals, Inc. (BLCM) financial statements (2020 and earlier)

Company profile

Business Address 2130 WEST HOLCOMBE BOULEVARD
HOUSTON, TX 77030
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:911034342935373
Cash and cash equivalents91994342445373
Short-term investments 41431496056
Other undisclosed cash, cash equivalents, and short-term investments  (14)(31) (60)(56)
Restricted cash and investments3      
Assets held-for-sale, not part of disposal group17      
Other undisclosed current assets12163426359
Total current assets:112105597795116132
Noncurrent Assets
Operating lease, right-of-use asset166 
Property, plant and equipment3161819212224
Restricted cash and investments 445566
Other noncurrent assets1333000
Other undisclosed noncurrent assets   5   
Total noncurrent assets:4293131262830
TOTAL ASSETS:11613490108122144162
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:101413101297
Accounts payable    4  
Accrued liabilities    9  
Employee-related liabilities2532 32
Other undisclosed accounts payable and accrued liabilities89108 66
Deferred revenue 11 
Debt1186 000
Deferred rent credit    000
Derivative instruments and hedges, liabilities5238     
Restructuring reserve 3     
Contract with customer, liability233 
Other undisclosed current liabilities211223 25
Total current liabilities:94762216161413
Noncurrent Liabilities
Long-term debt and lease obligation26 6 3600
Long-term debt, excluding current maturities26   36  
Capital lease obligations000
Operating lease, liability  6 
Liabilities, other than long-term debt    111
Deferred rent credit    111
Other undisclosed noncurrent liabilities1353141 3635
Total noncurrent liabilities:27353741373737
Total liabilities:1211115957535250
Temporary equity, carrying amount2122     
Stockholders' equity
Stockholders' equity attributable to parent(26)130516892113
Common stock1100000
Treasury stock, value(5)(5)(5)(5)(5)(5)(5)
Additional paid in capital512510507501494490487
Accumulated other comprehensive loss(0)(0)(0)(0)(0)(0)(0)
Accumulated deficit(533)(504)(472)(445)(421)(393)(370)
Total stockholders' equity:(26)130516892113
TOTAL LIABILITIES AND EQUITY:11613490108122144162

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Revenues5011000
Net investment income0000000
Cost of revenue
(Cost of Goods and Services Sold)
  (0)(0)   
Other undisclosed gross profit0   (0)  
Gross profit:5010000
Operating expenses(19)(24)(28)(24)(27)(24)(24)
Other undisclosed operating income (loss)(0)(0)000(0)(0)
Operating loss:(14)(23)(26)(24)(27)(23)(24)
Nonoperating expense(15)(9)(1)(1)(1)(1)(1)
Other nonoperating expense(0)(3)     
Interest and debt expense(1)(1)(1)(1)(1)(1)(1)
Net loss:(30)(33)(28)(26)(28)(25)(25)
Other undisclosed net income attributable to parent1111111
Net loss available to common stockholders, diluted:(29)(32)(27)(25)(27)(24)(24)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net loss:(30)(33)(28)(26)(28)(25)(25)
Other undisclosed comprehensive loss(113)   (98)  
Comprehensive loss:(143)(33)(28)(26)(126)(25)(25)
Other undisclosed comprehensive income, net of tax, attributable to parent1141119911
Comprehensive loss, net of tax, attributable to parent:(29)(32)(27)(24)(27)(24)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: